Market Research Life Sciences Market Research Medical Devices Market Research Catheters Market Research

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Best Price Guarantee Length Publisher Published Date SKU
from $4,000 102 Pages GlobalData March, 2022 GBDT17166105
Best Price Guarantee
Price from $4,000
Length 102 Pages
Publisher GlobalData
Published Date March, 2022
SKU GBDT17166105

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Summary

GlobalData's Medical Devices sector report, “PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 provides comprehensive information about the PTA Peripheral DCB Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the PTA Peripheral DCB Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of PTA Peripheral DCB Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage- Identify and understand important and diverse types of PTA Peripheral DCB Catheters under development- Develop market-entry and market expansion strategies- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline- In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • PTA Peripheral DCB Catheters Overview
  • Products under Development
    • PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
      • Table Figure 1: PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
      • Table PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
    • PTA Peripheral DCB Catheters - Pipeline Products by Territory
      • Table Figure 2: PTA Peripheral DCB Catheters - Pipeline Products by Territory
      • Table PTA Peripheral DCB Catheters - Pipeline Products by Territory
    • PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
      • Table Figure 3: PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
      • Table PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
    • PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
      • Table Figure 4: PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
      • Table PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
    • PTA Peripheral DCB Catheters - Ongoing Clinical Trials
      • Table Figure 5: PTA Peripheral DCB Catheters - Ongoing Clinical Trials
      • Table PTA Peripheral DCB Catheters - Ongoing Clinical Trials
  • PTA Peripheral DCB Catheters - Pipeline Products under Development by Companies
    • PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
      • Table PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
    • PTA Peripheral DCB Catheters - Companies Pipeline Products by Stage of Development
      • Table PTA Peripheral DCB Catheters - Companies Pipeline Products by Stage of Development
  • PTA Peripheral DCB Catheters Companies and Product Overview
    • AnGes Inc Company Overview
      • AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
        • Table NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
    • AngioCure, Inc. Company Overview
      • AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AngioCure TOP-C Smart Balloon Catheter - Product Status
        • Table AngioCure TOP-C Smart Balloon Catheter - Product Description
    • Ascenion GmbH Company Overview
      • Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Paclitaxel-Coated Balloon Catheter - Product Status
        • Table Paclitaxel-Coated Balloon Catheter - Product Description
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Product Status
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Product Description
        • Table Boston Scientific Corp - Ongoing Clinical Trials Overview
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - A Prospective, Single-Centre Study Investigating the Clinical Use and Safety of the Jetstream Atherectomy With Drug Coated Balloon (Ranger) for the Treatment of Dysfunctional Arterio- Venous Graft Stenosis
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Drug-eluting Registry: Real-world Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Efficacy of Rotational Atherectomy System Associated with Drug Coated Balloon Angioplasty (with or without Stent Placement) in the Management of Lower Limb Ischemia (ELLIPSE): "Real Life" Observational Study
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - JETStream AtheRectomy with Adjunctive Paclitaxel-coated Balloon Angioplasty Versus Balloon Angioplasty Followed by Paclitaxel-coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease: JET-RANGER
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Ranger Drug-coated Balloon Catheters Post Market Surveillance
        • Table Ranger Paclitaxel-Coated PTA Balloon Catheter - RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
    • Cardionovum GmbH Company Overview
      • Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table LEGFLOW OTW - Product Status
        • Table LEGFLOW OTW - Product Description
        • Table Cardionovum GmbH - Ongoing Clinical Trials Overview
        • Table LEGFLOW OTW - Evaluation of the Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation Catheter (LEGFLOW) in Treatment of Stenosis or Occlusion in Femoral-popliteal Arteries: A Prospective, Multicenter, Randomized, Controlled Clinical Study
        • Table LEGFLOW OTW - Evaluation the Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation
    • Chansu Vascular Technologies LLC Company Overview
      • Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peripheral Everolimus Drug-Coated Balloon - Product Status
        • Table Peripheral Everolimus Drug-Coated Balloon - Product Description
        • Table Chansu Vascular Technologies LLC - Ongoing Clinical Trials Overview
        • Table Peripheral Everolimus Drug-Coated Balloon - A First in-human Study Evaluating the Efficacy of Peripheral Everolimus Drug-coated Balloon in Patients with Peripheral Artery Disease: CVT-SFA
    • Concept Medical Inc Company Overview
      • Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MagicTouch PTA Balloon Catheter - Product Status
        • Table MagicTouch PTA Balloon Catheter - Product Description
        • Table Concept Medical Inc - Ongoing Clinical Trials Overview
        • Table MagicTouch PTA Balloon Catheter - Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
        • Table MagicTouch PTA Balloon Catheter - Head-to-Head Comparison of Sirolimus Versus Paclitaxel Drug-Eluting Balloon Angioplasty in the Femoropopliteal Artery
        • Table MagicTouch PTA Balloon Catheter - Major Adverse Limb Events in Patients with Femoro-popliteal and Below-theknee Peripheral Arterial Disease Treated with Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty
        • Table MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First SirolimUs Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below the Knee Arterial Disease: FUTURE BTK
        • Table MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Superficial Femoral Artery and Popliteal Artery Disease
    • Contego Medical LLC Company Overview
      • Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tibial Artery Drug Eluting Balloon - Product Status
        • Table Tibial Artery Drug Eluting Balloon - Product Description
    • eucatech AG Company Overview
      • eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Support - Product Status
        • Table Support - Product Description
    • Genesis MedTech International Pvt Ltd Company Overview
      • Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chocolate Touch - Product Status
        • Table Chocolate Touch - Product Description
        • Table Genesis MedTech International Pvt Ltd - Ongoing Clinical Trials Overview
        • Table Chocolate Touch - A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
    • Lifetech Scientific (Shenzhen) Co Ltd Company Overview
      • Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Status
        • Table FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Description
        • Table Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
        • Table FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Safety and Efficacy Study of FemFlow Drug-eluting
    • Lutonix Inc Company Overview
      • Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lutonix 014 Drug Coated Balloon PTA Catheter - Product Status
        • Table Lutonix 014 Drug Coated Balloon PTA Catheter - Product Description
    • M.A. Med Alliance SA Company Overview
      • M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Product Status
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Product Description
        • Table M.A. Med Alliance SA - Ongoing Clinical Trials Overview
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - A Prospective Multi-center Study to Assess the Safety and Efficacy of SELUTION SLR for the Treatment of Lesions of Superficial Femoral Arteries and/or Popliteal Arteries
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Intervention with Selution SLR Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Prospective Registry to Investigate the Safety and Efficacy of the Treatment with the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-inguinal Disease in Patients with Chronic Limb Threatening Ischemia from Singapore
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - SELUTION SLR 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis
        • Table SELUTION SLR 018 DEB - Peripheral Artery Disease - SUCCESS (Selution, Safety, Efficacy, Health Economics and Proms) PTA Study
    • Medtronic Plc Company Overview
      • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IN.PACT Admiral DEB - BTK - Product Status
        • Table IN.PACT Admiral DEB - BTK - Product Description
        • Table Medtronic Plc - Ongoing Clinical Trials Overview
        • Table IN.PACT Admiral DEB - BTK - Randomized Study of IN.PACT 014 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Chronic Total Occlusions in the Infrapopliteal Arteries
    • Micell Technologies Inc Company Overview
      • Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug-Coated Balloon - Product Status
        • Table Drug-Coated Balloon - Product Description
    • OrbusNeich Company Overview
      • OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
        • Table OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
        • Table Limus Drug Coated Balloon - Peripheral - Product Status
        • Table Limus Drug Coated Balloon - Peripheral - Product Description
    • Orchestra BioMed Inc Company Overview
      • Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Virtue Sirolimus-Eluting Balloon - BTK - Product Status
        • Table Virtue Sirolimus-Eluting Balloon - BTK - Product Description
    • Pulsus Medical LLC (Inactive) Company Overview
      • Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micro-Perforated Catheter Balloon Drug Delivery System - Product Status
        • Table Micro-Perforated Catheter Balloon Drug Delivery System - Product Description
    • QualiMed Innovative Medizinprodukte GmbH Company Overview
      • QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kinesyx-Based Peripheral Drug Coated Balloon - Product Status
        • Table Kinesyx-Based Peripheral Drug Coated Balloon - Product Description
    • Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
      • Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rapamycin Drug-Eluting Peripheral Balloon Catheter - Product Status
        • Table Rapamycin Drug-Eluting Peripheral Balloon Catheter - Product Description
    • SiL Vascular Ltd Company Overview
      • SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peripheral Vascular Balloon - Product Status
        • Table Peripheral Vascular Balloon - Product Description
    • Spectranetics Corp Company Overview
      • Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stellarex 0.014" Over-The-Wire Drug-Coated Angioplasty Balloon - Product Status
        • Table Stellarex 0.014" Over-The-Wire Drug-Coated Angioplasty Balloon - Product Description
        • Table Spectranetics Corp - Ongoing Clinical Trials Overview
        • Table Stellarex 0.014" Over-The-Wire Drug-Coated Angioplasty Balloon - Prospective, Multi-center Study to Evaluate Treatment of Subjects with Occlusive Disease with a Novel Paclitazel-coated Angioplasty Balloon in Below-the-knee (BTK) Arteries: A Post Market Clinical Study
    • Stemplant LLC Company Overview
      • Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peripheral Vascular Angioplasty Delivery Device - Product Status
        • Table Peripheral Vascular Angioplasty Delivery Device - Product Description
    • SurModics Inc Company Overview
      • SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Status
        • Table Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Description
        • Table Sundance BTK DCB - Product Status
        • Table Sundance BTK DCB - Product Description
        • Table SurVeil Drug Coated Balloon - Peripheral Artery Disease - Product Status
        • Table SurVeil Drug Coated Balloon - Peripheral Artery Disease - Product Description
        • Table SurModics Inc - Ongoing Clinical Trials Overview
        • Table SurVeil Drug Coated Balloon - Peripheral Artery Disease - A Prospective, Multi-center, Single-arm Study to Assess the Safety and Performance of the Surmodics Drug Coated Balloon in the Treatment of Subjects with Obstructive Lesions of Arteriovenous Fistulae for Hemodialysis, Including Native or Synthetic Grafts
        • Table SurVeil Drug Coated Balloon - Peripheral Artery Disease - The Randomized and Controlled Noninferiority Trial to Evaluate Safety and Clinical Efficacy of the SurVeil Drug-coated Balloon in the Treatment of Subjects with Stenotic Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
        • Table Sundance BTK DCB - A Prospective, Multi-center, Single-arm, Feasibility Study to Assess the Safety and Performance with the SUNDANCE DruG Coated Balloon for the Treatment of De Novo or Restenotic Lesions in Infra-popliteal Arteries
    • Tailored Medical Devices Inc Company Overview
      • Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MR-PEO-DCB - Product Status
        • Table MR-PEO-DCB - Product Description
    • TransMed7 LLC Company Overview
      • TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zeppelin II - Product Status
        • Table Zeppelin II - Product Description
    • Vascular Nanotransfer Technologies Company Overview
      • Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mitomycin-Based Drug Coated Balloon - Peripheral - Product Status
        • Table Mitomycin-Based Drug Coated Balloon - Peripheral - Product Description
        • Table Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Status
        • Table Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Description
    • Zylox-Tonbridge Medical Technology Co Ltd Company Overview
      • Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultrafree Drug Coated PTA Balloon Catheter - BTK - Product Status
        • Table Ultrafree Drug Coated PTA Balloon Catheter - BTK - Product Description
        • Table Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Product Status
        • Table Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Product Description
        • Table Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Product Status
        • Table Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Product Description
        • Table ZENFlow (Ultrafree) Drug-eluting PTA Balloon Dilatation Catheter - Product Status
        • Table ZENFlow (Ultrafree) Drug-eluting PTA Balloon Dilatation Catheter - Product Description
        • Table Zylox-Tonbridge Medical Technology Co Ltd - Ongoing Clinical Trials Overview
        • Table ZENFlow (Ultrafree) Drug-eluting PTA Balloon Dilatation Catheter - The Efficacy and Safety Study for Endovascular Treatment of Symptomatic Intracranial Atherosclerosis Using Drug-eluting Balloon Dilatation Catheter: An Prospective Multicenter Single-arm Trial
        • Table Ultrafree Drug Coated PTA Balloon Catheter - BTK - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for the Treatment of Stenosis or Occlusion in Below-the-knee
        • Table Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for Dialysis Access
        • Table Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for Vertebral Artery Stenosis
  • PTA Peripheral DCB Catheters- Recent Developments
    • Feb 10, 2022: Contego Medical Announces Hiring of Steve MacKinnon, Chief Commercialization Officer
    • Jan 13, 2022: QT Vascular Announces Appointment of Mr Thomas Tan Gim Chua as Chief Executive Officer and Executive Director
    • Jan 13, 2022: Qt Vascular Announces Appointment of Chief Operating Officer (Dental)
    • Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
    • Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
    • Nov 11, 2021: QT Vascular Reports Third Quarter Results For the Period 30 September 2021
    • Nov 11, 2021: Qt Vascular Announces Third Quarter Results
    • Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
    • Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021
    • Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
    • Oct 13, 2021: QT Vascular Announces Appointment of Executive Director
    • Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
    • Aug 13, 2021: QT Vascular Announces Condensed Interim Financial Statements for the six months ended 30 June 2021
    • Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
    • Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021
    • Jul 30, 2021: QT Vascular Announces Appointment of Independent Director
    • Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
    • Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
    • Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
    • May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
    • Apr 30, 2021: QT Vascular Announces Results of Annual General Meeting Held on 30 April 2021
    • Apr 30, 2021: Qt Vascular Notice of Annual General Meeting
    • Apr 15, 2021: Qt Vascular announces Annual General Meeting
    • Mar 26, 2021: Qt Vascular announce Financial Statements
    • Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
    • Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

$4,000
$8,000
$12,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings